FDA Biologics (BLA & Biosimilars)Original article
FDA Scientific Public Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics – September 23, 2026 - 09/23/2026
Neutral
AI Analysis
Summary
The FDA is hosting a scientific public workshop on September 23, 2026 to discuss next-generation sequencing technologies for adventitious agent detection in biological products, bringing together subject matter experts and stakeholders to identify challenges and explore solutions for adopting NGS-based methodologies.
Importance:2/10
Sentiment:
0.00
FDAworkshopnext-generation sequencingadventitious agent detectionbiologicsregulatory
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 25, 2026 3:01 PM